BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 8477800)

  • 1. Regulation of CD69 expression on human natural killer cells: differential involvement of protein kinase C and protein tyrosine kinases.
    Borrego F; Peña J; Solana R
    Eur J Immunol; 1993 May; 23(5):1039-43. PubMed ID: 8477800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Downregulation of Fc gamma receptor IIIA alpha (CD16-II) on natural killer cells induced by anti-CD16 mAb is independent of protein tyrosine kinases and protein kinase C.
    Borrego F; Lopez-Beltran A; Peña J; Solana R
    Cell Immunol; 1994 Oct; 158(1):208-17. PubMed ID: 8087866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signaling via CD7 molecules on human NK cells. Induction of tyrosine phosphorylation and beta 1 integrin-mediated adhesion to fibronectin.
    Rabinowich H; Lin WC; Herberman RB; Whiteside TL
    J Immunol; 1994 Oct; 153(8):3504-13. PubMed ID: 7523496
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein tyrosine phosphorylation and p56lck modification in IL-2 or phorbol ester-activated human natural killer cells.
    Einspahr KJ; Abraham RT; Dick CJ; Leibson PJ
    J Immunol; 1990 Sep; 145(5):1490-7. PubMed ID: 1696599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential effects of tyrosine kinase inhibition in CD69 antigen expression and lytic activity induced by rIL-2, rIL-12, and rIFN-alpha in human NK cells.
    Gerosa F; Tommasi M; Benati C; Gandini G; Libonati M; Tridente G; Carra G; Trinchieri G
    Cell Immunol; 1993 Sep; 150(2):382-90. PubMed ID: 8103709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fc gamma RIII activation is different in CD16+ cytotoxic T lymphocytes and natural killer cells.
    Uciechowski P; Gessner JE; Schindler R; Schmidt RE
    Eur J Immunol; 1992 Jun; 22(6):1635-8. PubMed ID: 1376268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential inhibition of T cell receptor signal transduction and early activation events by a selective inhibitor of protein-tyrosine kinase.
    Trevillyan JM; Lu YL; Atluru D; Phillips CA; Bjorndahl JM
    J Immunol; 1990 Nov; 145(10):3223-30. PubMed ID: 2172380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The human natural killer cell receptor for major histocompatibility complex class I molecules. Surface modulation of p58 molecules and their linkage to CD3 zeta chain, Fc epsilon RI gamma chain and the p56lck kinase.
    Bottino C; Vitale M; Olcese L; Sivori S; Morelli L; Augugliaro R; Ciccone E; Moretta L; Moretta A
    Eur J Immunol; 1994 Oct; 24(10):2527-34. PubMed ID: 7523145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of a metalloprotease in spontaneous and phorbol ester-induced release of natural killer cell-associated Fc gamma RIII (CD16-II).
    Harrison D; Phillips JH; Lanier LL
    J Immunol; 1991 Nov; 147(10):3459-65. PubMed ID: 1834741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ligation of the CD5 or CD28 molecules on resting human T cells induces expression of the early activation antigen CD69 by a calcium- and tyrosine kinase-dependent mechanism.
    Vandenberghe P; Verwilghen J; Van Vaeck F; Ceuppens JL
    Immunology; 1993 Feb; 78(2):210-7. PubMed ID: 7682535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes.
    Melero I; Salmerón A; Balboa MA; Aramburu J; López-Botet M
    J Immunol; 1994 Feb; 152(4):1662-73. PubMed ID: 8120376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T cell activation via Leu-23 (CD69).
    Testi R; Phillips JH; Lanier LL
    J Immunol; 1989 Aug; 143(4):1123-8. PubMed ID: 2501389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of CD16 (Fc receptor III) and interleukin-2 in the reactivation of natural killer cells after inhibitory target cell contact.
    Heiskala M; Ståhls A; Seppälä I; Timonen T
    Nat Immun Cell Growth Regul; 1991; 10(5):265-77. PubMed ID: 1836835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cord blood CD16+56- cells with low lytic activity are possible precursors of mature natural killer cells.
    Gaddy J; Broxmeyer HE
    Cell Immunol; 1997 Sep; 180(2):132-42. PubMed ID: 9341743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oligodeoxynucleotides containing palindrome sequences with internal 5'-CpG-3' act directly on human NK and activated T cells to induce IFN-gamma production in vitro.
    Iho S; Yamamoto T; Takahashi T; Yamamoto S
    J Immunol; 1999 Oct; 163(7):3642-52. PubMed ID: 10490958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective activation of resting human gamma delta T lymphocytes by interleukin-2.
    Kjeldsen-Kragh J; Quayle AJ; Skålhegg BS; Sioud M; Førre O
    Eur J Immunol; 1993 Sep; 23(9):2092-9. PubMed ID: 8370391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine kinase-dependent activation of human NK cell functions upon triggering through CD44 receptor.
    Galandrini R; Piccoli M; Frati L; Santoni A
    Eur J Immunol; 1996 Dec; 26(12):2807-11. PubMed ID: 8977272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
    Mihaylova I; DeRuyter M; Rummens JL; Bosmans E; Maes M
    Neuro Endocrinol Lett; 2007 Aug; 28(4):477-83. PubMed ID: 17693977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of norepinephrine-mediated inhibition of human NK cytotoxic functions: inhibition of cytokine secretion, target binding, and programming for cytotoxicity.
    Gan X; Zhang L; Solomon GF; Bonavida B
    Brain Behav Immun; 2002 Jun; 16(3):227-46. PubMed ID: 12009684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD56bright natural killer cell subsets: characterization of distinct functional responses to interleukin-2 and the c-kit ligand.
    Carson WE; Fehniger TA; Caligiuri MA
    Eur J Immunol; 1997 Feb; 27(2):354-60. PubMed ID: 9045904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.